vs
Side-by-side financial comparison of Bragg Gaming Group Inc. (BRAG) and Dogwood Therapeutics, Inc. (DWTX). Click either name above to swap in a different company.
Dogwood Therapeutics, Inc. is the larger business by last-quarter revenue ($22.8K vs $20.8K, roughly 1.1× Bragg Gaming Group Inc.). Bragg Gaming Group Inc. runs the higher net margin — 0.4% vs -5672.2%, a 5672.6% gap on every dollar of revenue.
Bragg Gaming Group Inc. is a global B2B provider of turnkey gaming technology solutions, content aggregation services, and player engagement tools for licensed online casino and sports betting operators. It primarily serves regulated online gambling markets across North America, Europe, and Latin America, offering fully customizable, compliance-aligned platform products for its client base.
Dogwood Therapeutics, Inc. is a clinical-stage biotechnology company focused on researching and developing targeted therapies for rare kidney diseases, metabolic disorders, and other unmet medical needs. It collaborates with global healthcare and research partners to advance its pipeline of innovative treatment candidates for patient populations worldwide.
BRAG vs DWTX — Head-to-Head
Income Statement — Q2 FY2022 vs Q1 FY2024
| Metric | | |
|---|---|---|
| Revenue | $20.8K | $22.8K |
| Net Profit | $90 | $-1.3M |
| Gross Margin | 55.9% | — |
| Operating Margin | 3.6% | -5772.2% |
| Net Margin | 0.4% | -5672.2% |
| Revenue YoY | — | -43.7% |
| Net Profit YoY | — | 14.9% |
| EPS (diluted) | $0.00 | $-1.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 24 | — | $22.8K | ||
| Q4 23 | — | $35.0K | ||
| Q3 23 | — | $39.2K | ||
| Q2 23 | — | $36.3K | ||
| Q1 23 | — | $40.4K | ||
| Q4 22 | — | $45.2K | ||
| Q3 22 | — | $16.6K | ||
| Q2 22 | $20.8K | $4.8K |
| Q1 24 | — | $-1.3M | ||
| Q4 23 | — | $-1.1M | ||
| Q3 23 | — | $-1.2M | ||
| Q2 23 | — | $-1.4M | ||
| Q1 23 | — | $-1.5M | ||
| Q4 22 | — | $-2.0M | ||
| Q3 22 | — | $-2.6M | ||
| Q2 22 | $90 | $-3.7M |
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | 55.9% | — |
| Q1 24 | — | -5772.2% | ||
| Q4 23 | — | -3256.2% | ||
| Q3 23 | — | -3249.5% | ||
| Q2 23 | — | -4068.0% | ||
| Q1 23 | — | -3852.5% | ||
| Q4 22 | — | -4627.4% | ||
| Q3 22 | — | -15611.7% | ||
| Q2 22 | 3.6% | -76437.5% |
| Q1 24 | — | -5672.2% | ||
| Q4 23 | — | -3156.2% | ||
| Q3 23 | — | -3149.5% | ||
| Q2 23 | — | -3968.0% | ||
| Q1 23 | — | -3752.5% | ||
| Q4 22 | — | -4527.4% | ||
| Q3 22 | — | -15511.7% | ||
| Q2 22 | 0.4% | -76337.5% |
| Q1 24 | — | $-1.68 | ||
| Q4 23 | — | $-5.27 | ||
| Q3 23 | — | $-1.62 | ||
| Q2 23 | — | $-0.08 | ||
| Q1 23 | — | $-0.08 | ||
| Q4 22 | — | $0.09 | ||
| Q3 22 | — | $-0.28 | ||
| Q2 22 | $0.00 | $-0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $2.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $2.7M |
| Total Assets | — | $3.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 24 | — | $2.4M | ||
| Q4 23 | — | $3.3M | ||
| Q3 23 | — | $4.8M | ||
| Q2 23 | — | $4.6M | ||
| Q1 23 | — | $5.3M | ||
| Q4 22 | — | $7.0M | ||
| Q3 22 | — | $9.8M | ||
| Q2 22 | — | $7.7M |
| Q1 24 | — | $2.7M | ||
| Q4 23 | — | $3.8M | ||
| Q3 23 | — | $4.8M | ||
| Q2 23 | — | $4.7M | ||
| Q1 23 | — | $6.0M | ||
| Q4 22 | — | $7.3M | ||
| Q3 22 | — | $9.2M | ||
| Q2 22 | — | $7.1M |
| Q1 24 | — | $3.2M | ||
| Q4 23 | — | $4.2M | ||
| Q3 23 | — | $5.2M | ||
| Q2 23 | — | $5.2M | ||
| Q1 23 | — | $6.5M | ||
| Q4 22 | — | $8.4M | ||
| Q3 22 | — | $10.9M | ||
| Q2 22 | — | $9.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $7.5K | $-937.4K |
| Free Cash FlowOCF − Capex | $7.3K | — |
| FCF MarginFCF / Revenue | 35.2% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | 82.92× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 24 | — | $-937.4K | ||
| Q4 23 | — | $-1.5M | ||
| Q3 23 | — | $-960.5K | ||
| Q2 23 | — | $-742.4K | ||
| Q1 23 | — | $-1.7M | ||
| Q4 22 | — | $-2.7M | ||
| Q3 22 | — | $-2.5M | ||
| Q2 22 | $7.5K | $-3.7M |
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | $7.3K | — |
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | 35.2% | — |
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | 0.7% | — |
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | 82.92× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRAG
| Other | $11.1K | 54% |
| Netherlands | $9.6K | 46% |
DWTX
Segment breakdown not available.
